↓ Skip to main content

The TREAT-NMD care and trial site registry: an online registry to facilitate clinical research for neuromuscular diseases

Overview of attention for article published in Orphanet Journal of Rare Diseases, October 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

blogs
1 blog
twitter
12 tweeters
facebook
2 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The TREAT-NMD care and trial site registry: an online registry to facilitate clinical research for neuromuscular diseases
Published in
Orphanet Journal of Rare Diseases, October 2013
DOI 10.1186/1750-1172-8-171
Pubmed ID
Authors

Sunil Rodger, Hanns Lochmüller, Adrian Tassoni, Kathrin Gramsch, Kirsten König, Kate Bushby, Volker Straub, Rudolf Korinthenberg, Janbernd Kirschner

Abstract

Rare diseases pose many research challenges specific to their scarcity. Advances in potential therapies have made it more important than ever to be able to adequately identify not only patients with particular genotypes (via patient registries) but also the medical professionals who provide care for them at particular specialist centres of expertise and who may be competent to participate in trials. Work within the neuromuscular field provides an example of how this may be achieved.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 2%
Unknown 40 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 17%
Other 6 15%
Researcher 6 15%
Student > Bachelor 4 10%
Student > Doctoral Student 3 7%
Other 8 20%
Unknown 7 17%
Readers by discipline Count As %
Medicine and Dentistry 12 29%
Biochemistry, Genetics and Molecular Biology 5 12%
Agricultural and Biological Sciences 5 12%
Social Sciences 4 10%
Nursing and Health Professions 2 5%
Other 6 15%
Unknown 7 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 March 2014.
All research outputs
#1,395,667
of 18,690,799 outputs
Outputs from Orphanet Journal of Rare Diseases
#128
of 2,001 outputs
Outputs of similar age
#16,236
of 198,661 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#2
of 28 outputs
Altmetric has tracked 18,690,799 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,001 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,661 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.